EGFR Primer Design

About EGFR

The EGFR gene (Epidermal Growth Factor Receptor, also known as ErbB1/HER1) on chromosome 7p12 encodes a transmembrane tyrosine kinase receptor involved in cell proliferation and survival. EGFR mutations, particularly in exons 18–21, are key drivers in non-small cell lung cancer (NSCLC). EGFR spans ~190 kb with 28 coding exons.

NCBI Gene ID: 1956 | RefSeq: NM_005228.5 | Genomic: NC_000007.14 (55086724-55275031)

EGFR Primer Design Challenges

• Hotspot mutation regions: Exons 18–21 contain common activating mutations (L858R, exon 19 deletions, T790M) requiring targeted amplicons
• GC-rich promoter: The 5' regulatory region has>70% GC content
• Large introns: Intron 1 alone spans ~120 kb, requiring careful exon-specific primer placement
• Alternative splicing: Multiple EGFR isoforms necessitate transcript-aware primer design
• Pseudogenes: EGFR pseudogene on chromosome 7 can interfere with genomic amplification

Recommended Primer Design Parameters for EGFR

Key SNPs to Avoid in Primer Binding Sites

When designing EGFR primers, avoid these clinically significant variants:

• rs121434568 (c.2573T>G, L858R) — Common lung cancer mutation in exon 21
• rs121434569 (c.2369C>T, T790M) — Resistance mutation in exon 20
• rs28929495 (c.2155G>T, G719C) — Exon 18 activating mutation
• Exon 19 deletions (c.2235_2249del15) — Common in-frame deletions in NSCLC

Recommended Primer Sequences for EGFR — Engine-Designed on NM_005228.5

The three pairs below were produced by VigyanLLM's automatic primer design engine directly against the Homo sapiens EGFR RefSeq mRNA NM_005228.5 (9905 nt), under the engine's default constraints: 18–25 nt primers, Tm 57–72 °C (optimum 62 °C), GC 40–60%, and an 80–1500 bp amplicon (optimum 150 bp). Every oligo was then re-checked back against the accession — each forward primer matches the sense strand at its stated 1-based position and each reverse primer matches the reverse complement ending at the amplicon's final base (3 of 3 exact matches for this page).

Pair 1 leads with a forward/reverse Tm spread of 0.0 °C, no stable hairpin at 37 °C (ΔG ≥ -0.5 kcal·mol⁻¹ on either oligo), self-dimer Tm at most -10.5 °C, no cross-dimer signal, no pair warnings, and a Primer3 pair-quality score of 100.0/100; the suggested starting annealing temperature is 53.5 °C. Pairs 2 and 3 are alternates from the same run — compare their Tm, GC and product columns above against your chemistry (dye-based or probe), then confirm every candidate in silico and on a gel before use.

How to read this table: these are default whole-transcript designs — they demonstrate what the engine produces under standard constraints and are not positioned over the clinically relevant variants discussed below; to land an amplicon on a specific codon or repeat, design against that region deliberately. Thermodynamics come from Primer3's nearest-neighbor engine (SantaLucia 1998). Example output only: validate each candidate experimentally (gel sizing, efficiency series, melt-curve or probe check) before relying on it.

Design Guidance for EGFR Assays

EGFR is a receptor tyrosine kinase; in non-small-cell lung cancer the driving alterations are exon 19 deletions (the canonical E746_A750del among them), the exon 21 point mutation L858R, and exon 20 insertions — the last of which also harbours the T790M resistance variant. In glioblastoma the EGFRvIII variant deletes exon 2 entirely.

For these assays the mutation must sit inside the amplicon with both primers in unchanged sequence, and products should stay at or below about 150 bp: circulating tumour DNA and DNA from FFPE sections is fragmented, and long amplicons simply drop out (the example pair above is 125 bp). Allele-specific formats invert the rule — the variant base is deliberately placed at the 3′ end of the allele-specific primer so extension proceeds only from the matching allele. Check both binding sites for common SNPs before ordering, and confirm specificity against your template type: a transcript-based check cannot see genomic context.

Practical checklist: (1) verify the binding sites in dbSNP/gnomAD so a common polymorphism does not sit under a primer; (2) confirm specificity against cDNA or gDNA as appropriate; (3) gradient the annealing temperature around 53.5 °C; (4) confirm one product of the expected size on a gel; (5) document sequence, lot, efficiency and transcript — MIQE-level reporting is what makes a result publishable.

References

• NCBI Nucleotide — RefSeq NM_005228.5 (Homo sapiens EGFR mRNA).
• NCBI Gene — EGFR (Homo sapiens).
• SantaLucia J Jr. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc Natl Acad Sci USA 1998;95:1460–1465.
• Untergasser A, Cutcutache I, Koressaar T, et al. Primer3—new capabilities and interfaces. Nucleic Acids Res 2012;40:W115–W118.
• Ye J, Coulouris G, Zaretskaya I, et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. Nucleic Acids Res 2009.
• Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611–622.